RCM
RA Capital Management’s Vor Biopharma VOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.2M | Hold |
39,646,039
| – | – | 1.08% | 24 |
|
|
2025
Q1 | $28.4M | Hold |
39,646,039
| – | – | 0.48% | 33 |
|
|
2024
Q4 | $44M | Buy |
39,646,039
+16,897,159
| +74% | +$18.8M | 0.59% | 36 |
|
|
2024
Q3 | $15.9M | Hold |
22,748,880
| – | – | 0.18% | 58 |
|
|
2024
Q2 | $22.7M | Hold |
22,748,880
| – | – | 0.3% | 50 |
|
|
2024
Q1 | $53.9M | Hold |
22,748,880
| – | – | 0.69% | 40 |
|
|
2023
Q4 | $51.2M | Hold |
22,748,880
| – | – | 0.8% | 32 |
|
|
2023
Q3 | $48.2M | Hold |
22,748,880
| – | – | 0.95% | 31 |
|
|
2023
Q2 | $70.3M | Hold |
22,748,880
| – | – | 1.33% | 23 |
|
|
2023
Q1 | $122M | Hold |
22,748,880
| – | – | 2.77% | 9 |
|
|
2022
Q4 | $151M | Buy |
22,748,880
+11,627,907
| +105% | +$77.3M | 3.07% | 8 |
|
|
2022
Q3 | $44.3M | Hold |
11,120,973
| – | – | 0.94% | 36 |
|
|
2022
Q2 | $55.3M | Hold |
11,120,973
| – | – | 1.47% | 21 |
|
|
2022
Q1 | $67.2M | Hold |
11,120,973
| – | – | 1.47% | 19 |
|
|
2021
Q4 | $129M | Hold |
11,120,973
| – | – | 2.28% | 11 |
|
|
2021
Q3 | $174M | Hold |
11,120,973
| – | – | 2.42% | 9 |
|
|
2021
Q2 | $207M | Hold |
11,120,973
| – | – | 3.33% | 5 |
|
|
2021
Q1 | $479M | Buy |
+11,120,973
| New | +$479M | 7.23% | 3 |
|